A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
BioNTech SE
BioNTech SE
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Curis, Inc.
National Institutes of Health Clinical Center (CC)
BeOne Medicines
BigHat Biosciences, Inc.
Dartsbio Pharmaceuticals Ltd.
Janssen Research & Development, LLC
Immatics US, Inc.
St. Jude Children's Research Hospital
T3 Pharmaceuticals AG
Novelwise Pharmaceutical Corporation
Merck Sharp & Dohme LLC
University of Arizona
Parabilis Medicines, Inc.
NaviFUS Corporation
Amgen
Pathos AI, Inc.
Cancer Research UK
Stemline Therapeutics, Inc.
Tasly Pharmaceutical Group Co., Ltd
Beijing Biotech
Lumos Pharma
Turning Point Therapeutics, Inc.
ModernaTX, Inc.
Corcept Therapeutics
Nanjing Leads Biolabs Co.,Ltd
ImmunityBio, Inc.
Children's Hospital of Philadelphia
Recurv Pharma Inc
iOnctura
LARKSPUR BIOSCIENCES, INC.
Eisai Inc.
University of Rochester
AstraZeneca
GlaxoSmithKline
Ensem Therapeutics
St. Jude Children's Research Hospital
Eisai Inc.
Peking Union Medical College Hospital
University of Southern California
NeoImmuneTech
University of Pennsylvania
Revolution Medicines, Inc.
Astellas Pharma Inc
Baptist Health South Florida
University of Chicago
Eli Lilly and Company